Swiss Peptide CDMO Manufacturers (2026)
The global peptide CDMO market hits $9B by 2036. How Bachem, PolyPeptide, and Lonza can build direct pipeline beyond GLP-1 anchor contracts.
May 2026 12 min read
The global peptide CDMO market hits $9B by 2036. How Bachem, PolyPeptide, and Lonza can build direct pipeline beyond GLP-1 anchor contracts.
Swiss hormone and steroid exports under HS 2937 hit $971M in 2024, lifted by GLP-1 demand. How peptide CDMOs and steroid producers reach buyers.